NASDAQ:VERU
Veru Stock News
$1.27
+0.0600 (+4.96%)
At Close: Apr 26, 2024
What Bear Market? These 3 Stocks Have Been Rocketing Higher in 2022
02:15pm, Thursday, 25'th Aug 2022 The Motley Fool
These three healthcare stocks have defied the 2022 bear market.
Got $2,500? These 2 Small-Cap Monsters Are Crushing Tesla Stock
02:53pm, Tuesday, 23'rd Aug 2022 The Motley Fool
It might not last forever, but for now they're preparing to grow aggressively.
Veru Granted Expedited Provisional Registration Regulatory Pathway for Sabizabulin Treatment in Hospitalized COVID-19 Patients by Australia’s Therapeutic Goods Administration
12:30pm, Monday, 22'nd Aug 2022 GlobeNewswire Inc.
MIAMI, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for th
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket
11:13am, Monday, 22'nd Aug 2022 Benzinga
Gainers
Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated publi
Signify Health And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
10:22am, Monday, 22'nd Aug 2022 Benzinga
Signify Health, Inc. (NYSE: SGFY) rose 36.8% to $29.00 in pre-market trading after the Wall Street Journal reported that Amazon.com, Inc. (NASDAQ: AMZN) is among the potential bidders for the healthc
Veru Announces Appointment of Jason Davies to Lead EMEA, LATAM and APAC Infectious Disease Franchise for Veru International Focused on Hospitalized COVID-19 Patients
12:30pm, Friday, 19'th Aug 2022 GlobeNewswire Inc.
MIAMI, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for th
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
07:54am, Friday, 19'th Aug 2022 Benzinga
Gainers
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
Plus Therapeutics, Inc. (NASDAQ: PSTV) shares climbed 53.9% to close at $0.8480
after the co
Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
04:54pm, Thursday, 18'th Aug 2022 Benzinga
Gainers
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) shares rose 50.9% to $1.1299 amid mention of the stock on Discord. Mind
Bed Bath & Beyond, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday
03:39pm, Thursday, 18'th Aug 2022 Benzinga
Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 23.3% to $17.71 following a Form 144 filing by RC Ventures, which suggested the firm proposed to sell 7.78 million common shares and certain call options. Ad
Dow Jumps Over 200 Points; Crude Oil Falls Sharply
04:10pm, Tuesday, 16'th Aug 2022 Benzinga
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 200 points on Tuesday.
The Dow traded up 0.71% to 34,154.30 while the NASDAQ fell 0.21% to 13,101.14. The S&P also
U.S. Stocks Trade Mixed; Dow Rises 75 Points
02:32pm, Tuesday, 16'th Aug 2022 Benzinga
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 75 points on Tuesday.
Following the market opening Tuesday, the Dow traded up 0.22% to 33,987.92 while the NASDAQ fell 0.71% to
This Growth Stock Has Soared Over 200% Year to Date -- Is It a Buy?
02:15pm, Tuesday, 16'th Aug 2022 The Motley Fool
More than two years into the pandemic, hospitalized patients with severe cases may get a game-changing treatment.
This Growth Stock Has Soared Over 200% Year to Date -- Is It a Buy?
10:15am, Tuesday, 16'th Aug 2022
More than two years into the pandemic, hospitalized patients with severe cases may get a game-changing treatment.
What Happened This Week: Musk Braces For Fight, Disney And Coinbase
02:26pm, Saturday, 13'th Aug 2022 Investing.com
Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
08:30pm, Friday, 12'th Aug 2022 GlobeNewswire Inc.
MIAMI, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for th
